anti-Toxoplasma gondii SAG1 antibody product blog
Tags: Antibody; Monoclonal Antibody; Toxoplasma gondii SAG1; anti-Toxoplasma gondii SAG1 antibody;
The Toxoplasma gondii SAG1 n/a (Catalog #MBS607010) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s Toxoplasma gondii SAG1 can be used in a range of immunoassay formats including, but not limited to, ELISA (EL/EIA), Western Blot (WB), Immunofluorescence (IF).Suitable for use in Immunofluorescence, ELISA and Western Blot.
Dilution: Immunofluorescence: 1:10-1:50
ELISA: 1:20-1:200
Western Blot: 1:10-1:50. Researchers should empirically determine the suitability of the Toxoplasma gondii SAG1 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Toxoplasma is a crescent shaped sporozoan that lives as intracellular parasite in various tissues of vertebrates and completes its life cycle in a single host. It is transmitted via raw/undercooked meat, contaminated soil, or by direct contact. Infection due to Toxoplasma gondii usually occurs in pregnant women where a variable degree of immunosuppression may exist or in patients receiving immunosuppressive drug therapy following organ transplant. Toxoplasma infects tissue of the GI tract where an active infection is accompanied by fever and enlargement of the spleen. Symptoms of toxoplasmosis are generally mild but severe infection of lymph nodes may occur. Congenital toxoplasmosis, in which the maternal infection is transmitted during pregnancy, can produce blindness or mental retardation in the newborn.
In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Toxoplasma gondii SAG1 are readily searchable from our website. Different antibodies against the same target such as Toxoplasma gondii SAG1 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.